Germany
September 24, 2004
by Patricia l. Short,
Chemical Engineering News via
Checkbiotech.org
Two of Germany’s chemicals giants
have given a big vote of confidence to biotechnology within the
agricultural sector.
Hans W. Reiners, president of
BASF’s agricultural products
division, told a recent media briefing in Limburgerhof, Germany,
that “2004 as a whole is going to be a successful year” for the
unit. The division is aiming to show an operating profit of 25%
by either next year or 2006; it already raised the figure to 21%
last year, up from 16% in 2002. Reiners said the division will
be aided by its research pipeline, which holds a growth
potential of $1.8 billion per year.
The group—expanded in the past couple of years through the
acquisitions of divisions of American Home Products and Bayer—is
reducing the number of active ingredients it sells from 300 in
2001 to fewer than 100; it currently has about 170 actives.
Recent product line divestitures will have taken out sales of
about $120 million this year, Reiners said.
The company has already opted to close its ag operations in
Mount Olive, N.J., splitting that work between sites in Raleigh,
N.C., and Ludwigshafen, Germany. And it is weighing how to
restructure its sites elsewhere, including in Brazil.
Separately, Bayer inaugurated
a new $20 million plant biotechnology innovation center in Gent,
Belgium, the largest and most modern research facility of its
bioscience group. The center marks an important milestone in
Bayer’s plant biotechnology strategy, said Friedrich Berschauer,
chairman of Bayer CropScience.
“Through the use of plant biotechnology and modern breeding,
plants will be enhanced to increase the quantity and quality of
food, feed, and fiber to the benefit of farmers, consumers, the
industry, and the environment,” he said. By the end of this
year, the bioscience unit will have invested about $100 million
in R&D to support products in its pipeline.
Copyright © 2004 Chemical & Engineering News |